Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian V Geisbrecht

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Protein Science : a Publication of the Protein Society|November 9, 2017
Evidence for multiple modes of neutrophil serine protease recognition by the EAP family of Staphylococcal innate immune evasion proteinsDaphne A C Stapels, Jordan L Woehl, Fin J Milder, et al.
The Journal of Biological Chemistry|February 8, 2018
Identification of a staphylococcal complement inhibitor with broad host specificity in equid <i>Staphylococcus aureus</i> strainsNienke W M de Jong, Manouk Vrieling, Brandon L Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2014
Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitorsDaphne A C Stapels, Kasra X Ramyar, Markus Bischoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertaseJordan L Woehl, Daphne A C Stapels, Brandon L Garcia, et al.
The Journal of Biological Chemistry|January 8, 2018
A structurally dynamic N-terminal region drives function of the staphylococcal peroxidase inhibitor (SPIN)Nienke W M de Jong, Nicoleta T Ploscariu, Kasra X Ramyar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2017
Immune evasion by a staphylococcal inhibitor of myeloperoxidaseNienke W M de Jong, Kasra X Ramyar, Fermin E Guerra, et al.
Cancer Research Communications|April 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical CancerSebastian O Wendel, Grant M Brooke, Changkun Hu, et al.
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Science Advances|September 28, 2022
Microfluidic affinity selection of active SARS-CoV-2 virus particlesSachindra S T Gamage, Thilanga N Pahattuge, Harshani Wijerathne, et al.
Nature Communications|June 11, 2026
Bacterial targeting of the neutrophil inhibitory receptor LILRB3 to evade antibody immunityMatevž Rumpret, Alexander L Lewis Marffy, Ying Zhang, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Protein Science : a Publication of the Protein Society|November 9, 2017
Evidence for multiple modes of neutrophil serine protease recognition by the EAP family of Staphylococcal innate immune evasion proteinsDaphne A C Stapels, Jordan L Woehl, Fin J Milder, et al.
The Journal of Biological Chemistry|February 8, 2018
Identification of a staphylococcal complement inhibitor with broad host specificity in equid <i>Staphylococcus aureus</i> strainsNienke W M de Jong, Manouk Vrieling, Brandon L Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2014
Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitorsDaphne A C Stapels, Kasra X Ramyar, Markus Bischoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertaseJordan L Woehl, Daphne A C Stapels, Brandon L Garcia, et al.
The Journal of Biological Chemistry|January 8, 2018
A structurally dynamic N-terminal region drives function of the staphylococcal peroxidase inhibitor (SPIN)Nienke W M de Jong, Nicoleta T Ploscariu, Kasra X Ramyar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2017
Immune evasion by a staphylococcal inhibitor of myeloperoxidaseNienke W M de Jong, Kasra X Ramyar, Fermin E Guerra, et al.
Cancer Research Communications|April 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical CancerSebastian O Wendel, Grant M Brooke, Changkun Hu, et al.
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Science Advances|September 28, 2022
Microfluidic affinity selection of active SARS-CoV-2 virus particlesSachindra S T Gamage, Thilanga N Pahattuge, Harshani Wijerathne, et al.
Nature Communications|June 11, 2026
Bacterial targeting of the neutrophil inhibitory receptor LILRB3 to evade antibody immunityMatevž Rumpret, Alexander L Lewis Marffy, Ying Zhang, et al.
Pageof 12